GSK plc

Insider Reports History

Entity
Company
Location
79 New Oxford Street, London, United Kingdom
Signature
/s/ Victoria Whyte, Authorized Signatory, GSK plc
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by GSK plc:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Wave Life Sciences Ltd. 10%+ Owner Ordinary Shares 16.8M $134M $8.00 Sep 27, 2024 By Corporation
Lyell Immunopharma, Inc. 10%+ Owner Common Stock 30.3M $69M $2.28 Jun 21, 2021 Indirect
CVRx, Inc. 10%+ Owner Common Stock 1.01M $18.7M $18.55 Jul 2, 2021 Indirect
Spero Therapeutics, Inc. 10%+ Owner Common Stock 9.19M $11.7M $1.27 Nov 7, 2022 Indirect
CVRx, Inc. 10%+ Owner Series B-2 Preferred Stock 0 Jul 2, 2021 Indirect
CVRx, Inc. 10%+ Owner Series C-2 Preferred Stock 0 Jul 2, 2021 Indirect
CVRx, Inc. 10%+ Owner Series D-2 Preferred Stock 0 Jul 2, 2021 Indirect
CVRx, Inc. 10%+ Owner Series E-2 Preferred Stock 0 Jul 2, 2021 Indirect
CVRx, Inc. 10%+ Owner Series F-2 Preferred Stock 0 Jul 2, 2021 Indirect
CVRx, Inc. 10%+ Owner Series G Preferred Stock 0 Jul 2, 2021 Indirect
Innoviva, Inc. 10%+ Owner Common Stock 0 $16.05 May 20, 2021 Indirect
Lyell Immunopharma, Inc. 10%+ Owner Series AA Preferred Stock 0 Jun 21, 2021 Indirect
Theravance Biopharma, Inc. Former 10% Owner Ordinary Shares 0 $10.29 Sep 16, 2022 By Corporation
Theravance Biopharma, Inc. Former 10% Owner Exchangeable Senior Notes due 2023 0 Sep 16, 2022 Indirect

Insider Reports Filed by GSK plc

Symbol Company Period Transactions Value $ Form Type Date Filed Role
WVE Wave Life Sciences Ltd. Sep 27, 2024 1 $22.3M 4 Oct 1, 2024 10%+ Owner
WVE Wave Life Sciences Ltd. Dec 7, 2023 1 $16.5M 4 Jan 30, 2024 10%+ Owner
WVE Wave Life Sciences Ltd. Jan 23, 2023 0 $0 3 Jan 30, 2023 10%+ Owner
SPRO Spero Therapeutics, Inc. Nov 7, 2022 0 $0 3 Nov 14, 2022 10%+ Owner
TBPH Theravance Biopharma, Inc. Sep 16, 2022 2 $175M 4 Sep 20, 2022 Former 10% Owner
CVRX CVRx, Inc. Jul 2, 2021 13 $4.95M 4 Jul 6, 2021 10%+ Owner
CVRX CVRx, Inc. Jun 29, 2021 0 $0 3 Jul 6, 2021 10%+ Owner
LYEL Lyell Immunopharma, Inc. Jun 21, 2021 2 $0 4 Jun 23, 2021 10%+ Owner
ME 23andMe Holding Co. Jun 16, 2021 0 $0 3 Nov 4, 2022 10%+ Owner
LYEL Lyell Immunopharma, Inc. Jun 16, 2021 0 $0 3 Jun 17, 2021 10%+ Owner
INVA Innoviva, Inc. May 20, 2021 1 -$392M 4 May 24, 2021 10%+ Owner